[144] Vor Biopharma Inc. SEC Filing

Rhea-AI Filing Summary

Vor Biopharma Inc. (VOR) Form 144 disclosure shows a proposed sale of 18,382 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $36,407.39 and an approximate sale date of 08/11/2025 on NASDAQ. The filing records that these shares were acquired as restricted stock on 08/01/2025 (12,696 shares) and 08/06/2025 (5,686 shares).

The notice also lists multiple sales by Robert Ang in June–July 2025 totaling 1,134,988 shares with gross proceeds of about $2,544,405.10. Several issuer and filer identification fields (including issuer name and filer CIK) are left blank in the form.

Positive

• Disclosure of broker and exchange used for the proposed sale: Morgan Stanley Smith Barney LLC on NASDAQ
• Transaction specifics provided: number of shares, aggregate market value, and acquisition dates for the shares proposed to be sold

Negative

• Extensive recent insider sales reported: 1,134,988 shares sold in June–July 2025 for gross proceeds of about $2,544,405.10
• Key identification fields missing: the filing content omits the issuer name and filer CIK as presented
• Filer relationship to issuer not stated in the provided content, limiting context for the sales

Insights

Securities Analyst

TL;DR: The filing discloses a small proposed sale of recently acquired restricted shares and large prior sales by Robert Ang totaling over one million shares.

The Form 144 identifies a proposed sale of 18,382 shares valued at $36,407.39 to be executed via Morgan Stanley Smith Barney LLC on NASDAQ. The same shares were acquired as restricted stock on 08/01/2025 and 08/06/2025. The document separately reports numerous prior sales by Robert Ang in June–July 2025 aggregating 1,134,988 shares for gross proceeds of approximately $2,544,405.10. These explicit figures are relevant to liquidity and insider selling patterns.

Corporate Governance Expert

TL;DR: The filing provides clear transaction details but omits issuer and filer identification fields, reducing transparency.

The form documents broker, exchange, acquisition dates, and transaction amounts, which supports regulatory disclosure. However, key fields such as the issuer name and filer CIK are blank in the provided content, and the filer’s relationship to the issuer is not stated. For governance and compliance review, those omissions are noteworthy because they limit immediate verification of insider status and context for the reported sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18382	36407.39	124959520	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2025	Restricted Stock	Issuer			5686	08/06/2025	Not Applicable
Common	08/01/2025	Restricted Stock	Issuer			12696	08/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/16/2025	45955	96441.16
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/16/2025	151982	318949.43
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/15/2025	8099	19877.38
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/15/2025	206036	500708.69
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/10/2025	84855	197160.59
Robert Ang 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/10/2025	512030	1190930.58
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/02/2025	30468	54537.72
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/02/2025	14468	25897.72
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/01/2025	16000	27523.20
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	07/01/2025	24468	42089.85
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	5686	9837.35
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	5686	9837.35
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	5686	9837.35
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	5259	9098.60
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	6624	11460.18
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	5686	9837.35
ROBERT ANG 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Common	06/30/2025	6000	10380.60

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the VOR Form 144 propose to sell?

The filing proposes sale of 18,382 common shares with aggregate market value $36,407.39 via Morgan Stanley Smith Barney LLC on NASDAQ (approximate date 08/11/2025).

When were the shares proposed for sale acquired?

The shares were recorded as restricted stock acquired on 08/01/2025 (12,696 shares) and 08/06/2025 (5,686 shares).

Who sold shares in the past three months according to the filing?

The filing lists multiple sales by Robert Ang in June–July 2025 totaling 1,134,988 shares for gross proceeds of about $2,544,405.10.

Does the Form 144 identify the issuer and filer CIK?

In the provided content the issuer name and filer CIK fields are blank and not populated.

Which broker is named for the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.